Acciones Magle Chemoswed Holding AB (publ) Nasdaq Stockholm
Acciones
SE0014401014
Farmacéuticos
Ventas 2024 * | 185 M 17,29 M 15,92 M | Ventas 2025 * | 216 M 20,16 M 18,56 M | Capitalización | 359 M 33,54 M 30,88 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 21 M 1,96 M 1,81 M | Resultado Neto 2025 * | 30 M 2,81 M 2,58 M | VE / Ventas 2024 * | 2,23 x |
Deuda neta 2024 * | 53,4 M 5 M 4,6 M | Deuda neta 2025 * | 42 M 3,93 M 3,62 M | VE / Ventas 2025 * | 1,86 x |
P/E ratio 2024 * |
17,5
x | P/E ratio 2025 * |
11,4
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 21,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Justin Pierce
CEO | Chief Executive Officer | 51 | 01/01/15 |
Petra Sjölin
DFI | Director of Finance/CFO | - | 01/07/20 |
Chief Operating Officer | 48 | 01/01/99 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 78 | 01/01/16 | |
Director/Board Member | 79 | 01/01/16 | |
Director/Board Member | 44 | 01/01/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+37,78 % | 723 mil M | |
+31,21 % | 598 mil M | |
-3,51 % | 364 mil M | |
+19,94 % | 331 mil M | |
+5,14 % | 288 mil M | |
+16,30 % | 244 mil M | |
-4,46 % | 208 mil M | |
+9,89 % | 210 mil M | |
+9,32 % | 169 mil M |